Science Explorer Back to mapMap
Discussion
Researcher · 3M (United States) · United States

John P. Vasilakos

John P. Vasilakos publishes mostly in Immunology, Molecular Biology and Epidemiology, on topics such as Immunotherapy and Immune Responses, Immune Response and Inflammation and Immune Cell Function and Interaction.

ORCID 0000-0002-1075-9665 OpenAlex
World rank
#205,304
of 7,710,434 ranked researchers
Rank in United States
#76,190
of 1,627,098
Works
70
Citations
6.6k
Citations per work
94.4
h-index
35
i10-index 47Top 11% in Immunology
John P. Vasilakos

What does John P. Vasilakos research?

John P. Vasilakos's work is mostly in Immunology and Microbiology (56%), Medicine (14%), Biochemistry, Genetics and Molecular Biology (6%).

Life Sciences: 43 works · 61.8% of their workImmunology and Microbiology: 39 works · 55.7% of their workImmunology: 37 works · 52.6% of their workMicrobiology: 2 works · 3.1% of their workBiochemistry, Genetics and Molecular Biology: 4 works · 6.1% of their workMolecular Biology: 4 works · 6.1% of their workEverything else: 17 works · 23.9% of their workHealth Sciences: 10 works · 14.3% of their workMedicine: 10 works · 14.3% of their workEpidemiology: 4 works · 5.6% of their workOncology: 4 works · 5.6% of their workInfectious Diseases: 2 works · 3.1% of their workTHEIR WORKJohn P. Vasilakos70works
Life Sciences62%Health Sciences14%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Immunology and Microbiology3955.7%
    2. Biochemistry, Genetics and Molecular Biology46.1%
  2. Everything else1723.9%
    1. Medicine1014.3%
  1. 1Immunology53% of their works
  2. 2Molecular Biology6% of their works
  3. 3Epidemiology6% of their works
  4. 4Oncology6% of their works
  5. 5Infectious Diseases3% of their works
  6. 6Microbiology3% of their works

Research topics

Which keywords describe John P. Vasilakos's research?

The keywords of their largest research topics: Innate Immunity, Dendritic Cells, Immunity, Pattern Recognition Receptors, Toll-like Receptors, Natural Killer Cells, NK Cell Recognition and Foxp3.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 17 words, with their numbers
  1. Innate Immunity372 topics
  2. Dendritic Cells321 topic
  3. Immunity321 topic
  4. Pattern Recognition Receptors311 topic
  5. Toll-like Receptors311 topic
  6. NK Cell Recognition181 topic
  7. Natural Killer Cells181 topic
  8. Foxp391 topic
  9. TGF-ß91 topic
  10. Immune Checkpoint Blockade81 topic
  11. PD-1 and PD-L181 topic
  12. Antimicrobial Peptides51 topic
  13. Candidiasis51 topic
  14. Hemicelluloses51 topic
  15. Host Defense51 topic
  16. Invasive Fungal Infections51 topic
  17. Pectin51 topic

Where does John P. Vasilakos work?

John P. Vasilakos's main affiliation in the publication record is 3M (United States), United States.

How many publications and citations does John P. Vasilakos have?

OpenAlex counts 70 works and 6,609 citations for John P. Vasilakos, an h-index of 35, ranking #205,304 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about John P. Vasilakos. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.